Global Cancer Tumor Profiling Supply, Demand and Key Producers, 2024-2030

Description

The global Cancer Tumor Profiling market size is expected to reach $ 78790 million by 2030, rising at a market growth of 10.0% CAGR during the forecast period (2024-2030).

The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth.

Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.

This report studies the global Cancer Tumor Profiling demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Cancer Tumor Profiling, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cancer Tumor Profiling that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Cancer Tumor Profiling total market, 2019-2030, (USD Million)
Global Cancer Tumor Profiling total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Cancer Tumor Profiling total market, key domestic companies and share, (USD Million)
Global Cancer Tumor Profiling revenue by player and market share 2019-2024, (USD Million)
Global Cancer Tumor Profiling total market by Type, CAGR, 2019-2030, (USD Million)
Global Cancer Tumor Profiling total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Cancer Tumor Profiling market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Qiagen N.V., Roche Molecular Systems Inc., Abott Molecular, Illumina Inc., NeoGenomics Laboratories, HTG Molecular Diagnostic, Genomic Health Inc., Hologic Gen-Probe and BD Biosciences, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cancer Tumor Profiling market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Cancer Tumor Profiling Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Cancer Tumor Profiling Market, Segmentation by Type
    Next-generation Sequencing (NGS)
    Polymerase Chain Reaction (PCR)
    Immunohistochemistry (IHC)
    In Situ Hybridization (ISH)
    Microarray
    Others

Global Cancer Tumor Profiling Market, Segmentation by Application
    Personalized Medicine
    Diagnostics
    Biomarker Discovery
    Prognostics
    Research Applications

Companies Profiled:
    Qiagen N.V.
    Roche Molecular Systems Inc.
    Abott Molecular
    Illumina Inc.
    NeoGenomics Laboratories
    HTG Molecular Diagnostic
    Genomic Health Inc.
    Hologic Gen-Probe
    BD Biosciences
    Siemens Healthineers
    Claris Life Sciences
    Personal Genome Diagnostics, Inc.
    Perthera, Inc.
    Foundation Medicine, Inc
    V., Strand
    ApoCell
    Contextual Genomics
    Agendia
    GenScript

Key Questions Answered
1. How big is the global Cancer Tumor Profiling market?
2. What is the demand of the global Cancer Tumor Profiling market?
3. What is the year over year growth of the global Cancer Tumor Profiling market?
4. What is the total value of the global Cancer Tumor Profiling market?
5. Who are the major players in the global Cancer Tumor Profiling market?

Table of Contents

1 Supply Summary
    1.1 Cancer Tumor Profiling Introduction
    1.2 World Cancer Tumor Profiling Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Cancer Tumor Profiling Total Market by Region (by Headquarter Location)
        1.3.1 World Cancer Tumor Profiling Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Cancer Tumor Profiling Market Size (2019-2030)
        1.3.3 China Cancer Tumor Profiling Market Size (2019-2030)
        1.3.4 Europe Cancer Tumor Profiling Market Size (2019-2030)
        1.3.5 Japan Cancer Tumor Profiling Market Size (2019-2030)
        1.3.6 South Korea Cancer Tumor Profiling Market Size (2019-2030)
        1.3.7 ASEAN Cancer Tumor Profiling Market Size (2019-2030)
        1.3.8 India Cancer Tumor Profiling Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Cancer Tumor Profiling Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Cancer Tumor Profiling Major Market Trends

2 Demand Summary
    2.1 World Cancer Tumor Profiling Consumption Value (2019-2030)
    2.2 World Cancer Tumor Profiling Consumption Value by Region
        2.2.1 World Cancer Tumor Profiling Consumption Value by Region (2019-2024)
        2.2.2 World Cancer Tumor Profiling Consumption Value Forecast by Region (2025-2030)
    2.3 United States Cancer Tumor Profiling Consumption Value (2019-2030)
    2.4 China Cancer Tumor Profiling Consumption Value (2019-2030)
    2.5 Europe Cancer Tumor Profiling Consumption Value (2019-2030)
    2.6 Japan Cancer Tumor Profiling Consumption Value (2019-2030)
    2.7 South Korea Cancer Tumor Profiling Consumption Value (2019-2030)
    2.8 ASEAN Cancer Tumor Profiling Consumption Value (2019-2030)
    2.9 India Cancer Tumor Profiling Consumption Value (2019-2030)

3 World Cancer Tumor Profiling Companies Competitive Analysis
    3.1 World Cancer Tumor Profiling Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Cancer Tumor Profiling Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Cancer Tumor Profiling in 2023
        3.2.3 Global Concentration Ratios (CR8) for Cancer Tumor Profiling in 2023
    3.3 Cancer Tumor Profiling Company Evaluation Quadrant
    3.4 Cancer Tumor Profiling Market: Overall Company Footprint Analysis
        3.4.1 Cancer Tumor Profiling Market: Region Footprint
        3.4.2 Cancer Tumor Profiling Market: Company Product Type Footprint
        3.4.3 Cancer Tumor Profiling Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Cancer Tumor Profiling Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Cancer Tumor Profiling Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Cancer Tumor Profiling Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Cancer Tumor Profiling Consumption Value Comparison
        4.2.1 United States VS China: Cancer Tumor Profiling Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Cancer Tumor Profiling Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Cancer Tumor Profiling Companies and Market Share, 2019-2024
        4.3.1 United States Based Cancer Tumor Profiling Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Cancer Tumor Profiling Revenue, (2019-2024)
    4.4 China Based Companies Cancer Tumor Profiling Revenue and Market Share, 2019-2024
        4.4.1 China Based Cancer Tumor Profiling Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Cancer Tumor Profiling Revenue, (2019-2024)
    4.5 Rest of World Based Cancer Tumor Profiling Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Cancer Tumor Profiling Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Cancer Tumor Profiling Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Cancer Tumor Profiling Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Next-generation Sequencing (NGS)
        5.2.2 Polymerase Chain Reaction (PCR)
        5.2.3 Immunohistochemistry (IHC)
        5.2.4 In Situ Hybridization (ISH)
        5.2.5 Microarray
        5.2.6 Others
    5.3 Market Segment by Type
        5.3.1 World Cancer Tumor Profiling Market Size by Type (2019-2024)
        5.3.2 World Cancer Tumor Profiling Market Size by Type (2025-2030)
        5.3.3 World Cancer Tumor Profiling Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Cancer Tumor Profiling Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Personalized Medicine
        6.2.2 Diagnostics
        6.2.3 Biomarker Discovery
        6.2.4 Prognostics
        6.2.5 Prognostics
    6.3 Market Segment by Application
        6.3.1 World Cancer Tumor Profiling Market Size by Application (2019-2024)
        6.3.2 World Cancer Tumor Profiling Market Size by Application (2025-2030)
        6.3.3 World Cancer Tumor Profiling Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Qiagen N.V.
        7.1.1 Qiagen N.V. Details
        7.1.2 Qiagen N.V. Major Business
        7.1.3 Qiagen N.V. Cancer Tumor Profiling Product and Services
        7.1.4 Qiagen N.V. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Qiagen N.V. Recent Developments/Updates
        7.1.6 Qiagen N.V. Competitive Strengths & Weaknesses
    7.2 Roche Molecular Systems Inc.
        7.2.1 Roche Molecular Systems Inc. Details
        7.2.2 Roche Molecular Systems Inc. Major Business
        7.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Product and Services
        7.2.4 Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Roche Molecular Systems Inc. Recent Developments/Updates
        7.2.6 Roche Molecular Systems Inc. Competitive Strengths & Weaknesses
    7.3 Abott Molecular
        7.3.1 Abott Molecular Details
        7.3.2 Abott Molecular Major Business
        7.3.3 Abott Molecular Cancer Tumor Profiling Product and Services
        7.3.4 Abott Molecular Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Abott Molecular Recent Developments/Updates
        7.3.6 Abott Molecular Competitive Strengths & Weaknesses
    7.4 Illumina Inc.
        7.4.1 Illumina Inc. Details
        7.4.2 Illumina Inc. Major Business
        7.4.3 Illumina Inc. Cancer Tumor Profiling Product and Services
        7.4.4 Illumina Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Illumina Inc. Recent Developments/Updates
        7.4.6 Illumina Inc. Competitive Strengths & Weaknesses
    7.5 NeoGenomics Laboratories
        7.5.1 NeoGenomics Laboratories Details
        7.5.2 NeoGenomics Laboratories Major Business
        7.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Product and Services
        7.5.4 NeoGenomics Laboratories Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 NeoGenomics Laboratories Recent Developments/Updates
        7.5.6 NeoGenomics Laboratories Competitive Strengths & Weaknesses
    7.6 HTG Molecular Diagnostic
        7.6.1 HTG Molecular Diagnostic Details
        7.6.2 HTG Molecular Diagnostic Major Business
        7.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Product and Services
        7.6.4 HTG Molecular Diagnostic Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 HTG Molecular Diagnostic Recent Developments/Updates
        7.6.6 HTG Molecular Diagnostic Competitive Strengths & Weaknesses
    7.7 Genomic Health Inc.
        7.7.1 Genomic Health Inc. Details
        7.7.2 Genomic Health Inc. Major Business
        7.7.3 Genomic Health Inc. Cancer Tumor Profiling Product and Services
        7.7.4 Genomic Health Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Genomic Health Inc. Recent Developments/Updates
        7.7.6 Genomic Health Inc. Competitive Strengths & Weaknesses
    7.8 Hologic Gen-Probe
        7.8.1 Hologic Gen-Probe Details
        7.8.2 Hologic Gen-Probe Major Business
        7.8.3 Hologic Gen-Probe Cancer Tumor Profiling Product and Services
        7.8.4 Hologic Gen-Probe Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Hologic Gen-Probe Recent Developments/Updates
        7.8.6 Hologic Gen-Probe Competitive Strengths & Weaknesses
    7.9 BD Biosciences
        7.9.1 BD Biosciences Details
        7.9.2 BD Biosciences Major Business
        7.9.3 BD Biosciences Cancer Tumor Profiling Product and Services
        7.9.4 BD Biosciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 BD Biosciences Recent Developments/Updates
        7.9.6 BD Biosciences Competitive Strengths & Weaknesses
    7.10 Siemens Healthineers
        7.10.1 Siemens Healthineers Details
        7.10.2 Siemens Healthineers Major Business
        7.10.3 Siemens Healthineers Cancer Tumor Profiling Product and Services
        7.10.4 Siemens Healthineers Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Siemens Healthineers Recent Developments/Updates
        7.10.6 Siemens Healthineers Competitive Strengths & Weaknesses
    7.11 Claris Life Sciences
        7.11.1 Claris Life Sciences Details
        7.11.2 Claris Life Sciences Major Business
        7.11.3 Claris Life Sciences Cancer Tumor Profiling Product and Services
        7.11.4 Claris Life Sciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Claris Life Sciences Recent Developments/Updates
        7.11.6 Claris Life Sciences Competitive Strengths & Weaknesses
    7.12 Personal Genome Diagnostics, Inc.
        7.12.1 Personal Genome Diagnostics, Inc. Details
        7.12.2 Personal Genome Diagnostics, Inc. Major Business
        7.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product and Services
        7.12.4 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Personal Genome Diagnostics, Inc. Recent Developments/Updates
        7.12.6 Personal Genome Diagnostics, Inc. Competitive Strengths & Weaknesses
    7.13 Perthera, Inc.
        7.13.1 Perthera, Inc. Details
        7.13.2 Perthera, Inc. Major Business
        7.13.3 Perthera, Inc. Cancer Tumor Profiling Product and Services
        7.13.4 Perthera, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Perthera, Inc. Recent Developments/Updates
        7.13.6 Perthera, Inc. Competitive Strengths & Weaknesses
    7.14 Foundation Medicine, Inc
        7.14.1 Foundation Medicine, Inc Details
        7.14.2 Foundation Medicine, Inc Major Business
        7.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Product and Services
        7.14.4 Foundation Medicine, Inc Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Foundation Medicine, Inc Recent Developments/Updates
        7.14.6 Foundation Medicine, Inc Competitive Strengths & Weaknesses
    7.15 V., Strand
        7.15.1 V., Strand Details
        7.15.2 V., Strand Major Business
        7.15.3 V., Strand Cancer Tumor Profiling Product and Services
        7.15.4 V., Strand Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 V., Strand Recent Developments/Updates
        7.15.6 V., Strand Competitive Strengths & Weaknesses
    7.16 ApoCell
        7.16.1 ApoCell Details
        7.16.2 ApoCell Major Business
        7.16.3 ApoCell Cancer Tumor Profiling Product and Services
        7.16.4 ApoCell Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 ApoCell Recent Developments/Updates
        7.16.6 ApoCell Competitive Strengths & Weaknesses
    7.17 Contextual Genomics
        7.17.1 Contextual Genomics Details
        7.17.2 Contextual Genomics Major Business
        7.17.3 Contextual Genomics Cancer Tumor Profiling Product and Services
        7.17.4 Contextual Genomics Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 Contextual Genomics Recent Developments/Updates
        7.17.6 Contextual Genomics Competitive Strengths & Weaknesses
    7.18 Agendia
        7.18.1 Agendia Details
        7.18.2 Agendia Major Business
        7.18.3 Agendia Cancer Tumor Profiling Product and Services
        7.18.4 Agendia Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.18.5 Agendia Recent Developments/Updates
        7.18.6 Agendia Competitive Strengths & Weaknesses
    7.19 GenScript
        7.19.1 GenScript Details
        7.19.2 GenScript Major Business
        7.19.3 GenScript Cancer Tumor Profiling Product and Services
        7.19.4 GenScript Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024)
        7.19.5 GenScript Recent Developments/Updates
        7.19.6 GenScript Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Cancer Tumor Profiling Industry Chain
    8.2 Cancer Tumor Profiling Upstream Analysis
    8.3 Cancer Tumor Profiling Midstream Analysis
    8.4 Cancer Tumor Profiling Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Cancer Tumor Profiling Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Cancer Tumor Profiling Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Cancer Tumor Profiling Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Cancer Tumor Profiling Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Cancer Tumor Profiling Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Cancer Tumor Profiling Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Cancer Tumor Profiling Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Cancer Tumor Profiling Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Cancer Tumor Profiling Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Cancer Tumor Profiling Players in 2023
    Table 12. World Cancer Tumor Profiling Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Cancer Tumor Profiling Company Evaluation Quadrant
    Table 14. Head Office of Key Cancer Tumor Profiling Player
    Table 15. Cancer Tumor Profiling Market: Company Product Type Footprint
    Table 16. Cancer Tumor Profiling Market: Company Product Application Footprint
    Table 17. Cancer Tumor Profiling Mergers & Acquisitions Activity
    Table 18. United States VS China Cancer Tumor Profiling Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Cancer Tumor Profiling Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Cancer Tumor Profiling Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Cancer Tumor Profiling Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Cancer Tumor Profiling Revenue Market Share (2019-2024)
    Table 23. China Based Cancer Tumor Profiling Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Cancer Tumor Profiling Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Cancer Tumor Profiling Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Cancer Tumor Profiling Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Cancer Tumor Profiling Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Cancer Tumor Profiling Revenue Market Share (2019-2024)
    Table 29. World Cancer Tumor Profiling Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Cancer Tumor Profiling Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Cancer Tumor Profiling Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Cancer Tumor Profiling Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Cancer Tumor Profiling Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Cancer Tumor Profiling Market Size by Application (2025-2030) & (USD Million)
    Table 35. Qiagen N.V. Basic Information, Area Served and Competitors
    Table 36. Qiagen N.V. Major Business
    Table 37. Qiagen N.V. Cancer Tumor Profiling Product and Services
    Table 38. Qiagen N.V. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Qiagen N.V. Recent Developments/Updates
    Table 40. Qiagen N.V. Competitive Strengths & Weaknesses
    Table 41. Roche Molecular Systems Inc. Basic Information, Area Served and Competitors
    Table 42. Roche Molecular Systems Inc. Major Business
    Table 43. Roche Molecular Systems Inc. Cancer Tumor Profiling Product and Services
    Table 44. Roche Molecular Systems Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Roche Molecular Systems Inc. Recent Developments/Updates
    Table 46. Roche Molecular Systems Inc. Competitive Strengths & Weaknesses
    Table 47. Abott Molecular Basic Information, Area Served and Competitors
    Table 48. Abott Molecular Major Business
    Table 49. Abott Molecular Cancer Tumor Profiling Product and Services
    Table 50. Abott Molecular Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Abott Molecular Recent Developments/Updates
    Table 52. Abott Molecular Competitive Strengths & Weaknesses
    Table 53. Illumina Inc. Basic Information, Area Served and Competitors
    Table 54. Illumina Inc. Major Business
    Table 55. Illumina Inc. Cancer Tumor Profiling Product and Services
    Table 56. Illumina Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Illumina Inc. Recent Developments/Updates
    Table 58. Illumina Inc. Competitive Strengths & Weaknesses
    Table 59. NeoGenomics Laboratories Basic Information, Area Served and Competitors
    Table 60. NeoGenomics Laboratories Major Business
    Table 61. NeoGenomics Laboratories Cancer Tumor Profiling Product and Services
    Table 62. NeoGenomics Laboratories Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. NeoGenomics Laboratories Recent Developments/Updates
    Table 64. NeoGenomics Laboratories Competitive Strengths & Weaknesses
    Table 65. HTG Molecular Diagnostic Basic Information, Area Served and Competitors
    Table 66. HTG Molecular Diagnostic Major Business
    Table 67. HTG Molecular Diagnostic Cancer Tumor Profiling Product and Services
    Table 68. HTG Molecular Diagnostic Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. HTG Molecular Diagnostic Recent Developments/Updates
    Table 70. HTG Molecular Diagnostic Competitive Strengths & Weaknesses
    Table 71. Genomic Health Inc. Basic Information, Area Served and Competitors
    Table 72. Genomic Health Inc. Major Business
    Table 73. Genomic Health Inc. Cancer Tumor Profiling Product and Services
    Table 74. Genomic Health Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Genomic Health Inc. Recent Developments/Updates
    Table 76. Genomic Health Inc. Competitive Strengths & Weaknesses
    Table 77. Hologic Gen-Probe Basic Information, Area Served and Competitors
    Table 78. Hologic Gen-Probe Major Business
    Table 79. Hologic Gen-Probe Cancer Tumor Profiling Product and Services
    Table 80. Hologic Gen-Probe Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Hologic Gen-Probe Recent Developments/Updates
    Table 82. Hologic Gen-Probe Competitive Strengths & Weaknesses
    Table 83. BD Biosciences Basic Information, Area Served and Competitors
    Table 84. BD Biosciences Major Business
    Table 85. BD Biosciences Cancer Tumor Profiling Product and Services
    Table 86. BD Biosciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. BD Biosciences Recent Developments/Updates
    Table 88. BD Biosciences Competitive Strengths & Weaknesses
    Table 89. Siemens Healthineers Basic Information, Area Served and Competitors
    Table 90. Siemens Healthineers Major Business
    Table 91. Siemens Healthineers Cancer Tumor Profiling Product and Services
    Table 92. Siemens Healthineers Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Siemens Healthineers Recent Developments/Updates
    Table 94. Siemens Healthineers Competitive Strengths & Weaknesses
    Table 95. Claris Life Sciences Basic Information, Area Served and Competitors
    Table 96. Claris Life Sciences Major Business
    Table 97. Claris Life Sciences Cancer Tumor Profiling Product and Services
    Table 98. Claris Life Sciences Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Claris Life Sciences Recent Developments/Updates
    Table 100. Claris Life Sciences Competitive Strengths & Weaknesses
    Table 101. Personal Genome Diagnostics, Inc. Basic Information, Area Served and Competitors
    Table 102. Personal Genome Diagnostics, Inc. Major Business
    Table 103. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product and Services
    Table 104. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Personal Genome Diagnostics, Inc. Recent Developments/Updates
    Table 106. Personal Genome Diagnostics, Inc. Competitive Strengths & Weaknesses
    Table 107. Perthera, Inc. Basic Information, Area Served and Competitors
    Table 108. Perthera, Inc. Major Business
    Table 109. Perthera, Inc. Cancer Tumor Profiling Product and Services
    Table 110. Perthera, Inc. Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. Perthera, Inc. Recent Developments/Updates
    Table 112. Perthera, Inc. Competitive Strengths & Weaknesses
    Table 113. Foundation Medicine, Inc Basic Information, Area Served and Competitors
    Table 114. Foundation Medicine, Inc Major Business
    Table 115. Foundation Medicine, Inc Cancer Tumor Profiling Product and Services
    Table 116. Foundation Medicine, Inc Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 117. Foundation Medicine, Inc Recent Developments/Updates
    Table 118. Foundation Medicine, Inc Competitive Strengths & Weaknesses
    Table 119. V., Strand Basic Information, Area Served and Competitors
    Table 120. V., Strand Major Business
    Table 121. V., Strand Cancer Tumor Profiling Product and Services
    Table 122. V., Strand Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 123. V., Strand Recent Developments/Updates
    Table 124. V., Strand Competitive Strengths & Weaknesses
    Table 125. ApoCell Basic Information, Area Served and Competitors
    Table 126. ApoCell Major Business
    Table 127. ApoCell Cancer Tumor Profiling Product and Services
    Table 128. ApoCell Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 129. ApoCell Recent Developments/Updates
    Table 130. ApoCell Competitive Strengths & Weaknesses
    Table 131. Contextual Genomics Basic Information, Area Served and Competitors
    Table 132. Contextual Genomics Major Business
    Table 133. Contextual Genomics Cancer Tumor Profiling Product and Services
    Table 134. Contextual Genomics Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 135. Contextual Genomics Recent Developments/Updates
    Table 136. Contextual Genomics Competitive Strengths & Weaknesses
    Table 137. Agendia Basic Information, Area Served and Competitors
    Table 138. Agendia Major Business
    Table 139. Agendia Cancer Tumor Profiling Product and Services
    Table 140. Agendia Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 141. Agendia Recent Developments/Updates
    Table 142. GenScript Basic Information, Area Served and Competitors
    Table 143. GenScript Major Business
    Table 144. GenScript Cancer Tumor Profiling Product and Services
    Table 145. GenScript Cancer Tumor Profiling Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 146. Global Key Players of Cancer Tumor Profiling Upstream (Raw Materials)
    Table 147. Cancer Tumor Profiling Typical Customers
List of Figure
    Figure 1. Cancer Tumor Profiling Picture
    Figure 2. World Cancer Tumor Profiling Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Cancer Tumor Profiling Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Cancer Tumor Profiling Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Cancer Tumor Profiling Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Cancer Tumor Profiling Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Cancer Tumor Profiling Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Cancer Tumor Profiling Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Cancer Tumor Profiling Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Cancer Tumor Profiling Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Cancer Tumor Profiling Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Cancer Tumor Profiling Revenue (2019-2030) & (USD Million)
    Figure 13. Cancer Tumor Profiling Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Cancer Tumor Profiling Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Cancer Tumor Profiling Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Cancer Tumor Profiling by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Cancer Tumor Profiling Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Cancer Tumor Profiling Markets in 2023
    Figure 27. United States VS China: Cancer Tumor Profiling Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Cancer Tumor Profiling Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Cancer Tumor Profiling Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Cancer Tumor Profiling Market Size Market Share by Type in 2023
    Figure 31. Next-generation Sequencing (NGS)
    Figure 32. Polymerase Chain Reaction (PCR)
    Figure 33. Immunohistochemistry (IHC)
    Figure 34. In Situ Hybridization (ISH)
    Figure 35. Microarray
    Figure 36. Others
    Figure 37. World Cancer Tumor Profiling Market Size Market Share by Type (2019-2030)
    Figure 38. World Cancer Tumor Profiling Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 39. World Cancer Tumor Profiling Market Size Market Share by Application in 2023
    Figure 40. Personalized Medicine
    Figure 41. Diagnostics
    Figure 42. Biomarker Discovery
    Figure 43. Prognostics
    Figure 44. Research Applications
    Figure 45. Cancer Tumor Profiling Industrial Chain
    Figure 46. Methodology
    Figure 47. Research Process and Data Source

Companies Mentioned

Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript